Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome
Top Cited Papers
Open Access
- 2 January 2013
- journal article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 13 (1), 1
- https://doi.org/10.1186/1471-2407-13-1
Abstract
Breast cancer is a potentially fatal malignancy in females despite the improvement in therapeutic techniques. The identification of novel molecular signatures is needed for earlier detection, monitoring effects of treatment, and predicting prognosis. We have previously used microarray analysis to identify differentially expressed genes in aggressive breast tumors. The purpose of the present study was to investigate the prognostic value of the candidate biomarkers CCNB2, ASPM, CDCA7, KIAA0101, and SLC27A2 in breast cancer. The expression levels and subcellular localization of the CCNB2, ASPM, CDCA7, KIAA0101, and SLC27A2 proteins were measured using immunohistochemistry (IHC) on a panel of 80 primary invasive breast tumors. Furthermore, the mRNA levels of CCNB2, KIAA0101, and SLC27A2 were subsequently examined by qRT-PCR to validate IHC results. Patient disease-specific survival (DSS) was evaluated in correlation to protein levels using the Kaplan-Meier method. Multivariate Cox regression analysis was used to determine the impact of aberrant protein expression of the candidate biomarkers on patient DSS and to estimate the hazard ratio at 8-year follow-up. Elevated cytoplasmic CCNB2 protein levels were strongly associated with short-term disease-specific survival of breast cancer patients (≤ 8 years; P<0.001) and with histological tumor type (P= 0.04). However, no association with other clinicopathological parameters was observed. Multivariate Cox regression analysis specified that CCNB2 protein expression is an independent prognostic marker of DSS in breast cancer. The predictive ability of several classical clinicopathological parameters was improved when used in conjunction with CCNB2 protein expression (C-index = 0.795) in comparison with a model without CCNB2 expression (C-index = 0.698). The protein levels of ASPM, CDCA7, KIAA0101, and SLC27A2 did not correlate with any clinicopathological parameter and had no influence on DSS. However, a significant correlation between the expression of the CCNB2 and ASPM proteins was detected (P = 0.03). These findings suggest that cytoplasmic CCNB2 may function as an oncogene and could serve as a potential biomarker of unfavorable prognosis over short-term follow-up in breast cancer.Keywords
This publication has 47 references indexed in Scilit:
- KIAA0101 Interacts with BRCA1 and Regulates Centrosome NumberMolecular Cancer Research, 2011
- ASPM and microcephalin expression in epithelial ovarian cancer correlates with tumour grade and survivalBritish Journal of Cancer, 2011
- Human ASPM participates in spindle organisation, spindle orientation and cytokinesisBMC Cell Biology, 2010
- Regulation of Cyclin B2 Expression and Cell Cycle G2/M Transition by MeninOnline Journal of Public Health Informatics, 2010
- Hepatitis C Virus NS5A Protein Down-regulates the Expression of Spindle Gene Aspm through PKR-p38 Signaling PathwayOnline Journal of Public Health Informatics, 2008
- Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular targetProceedings of the National Academy of Sciences of the United States of America, 2006
- Aspm specifically maintains symmetric proliferative divisions of neuroepithelial cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancerOncogene, 2004
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991